Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-006696

Options or other derivatives

  • SVP,Clinical & Medical Affairs acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hogge Gary S. · SVP,Clinical & Medical Affairs

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-10 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +450,000 450,000 D
Loading xslF345X03/ownership.xml…